share_log

Adaptimmune Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%), etc.

Adaptimmune Therapeutics | SC 13G:超过5%持股股东披露文件-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%)等

SEC announcement ·  01/30 17:29
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息